Gabriel S. Morris - 08 Dec 2025 Form 4 Insider Report for Immix Biopharma, Inc. (IMMX)

Reporting relationship: CFO, Director
Issuer ticker: IMMX
Reported as of: 08 Dec 2025
Net transaction value: +$129,867
SEC form: 4
Accepted by SEC: 10 Dec 2025, 18:47:20 UTC
Prior SEC filing: 17 Sep 2025
Next SEC filing: 29 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Gabriel Morris

Key filing fact

Gabriel S. Morris filed Form 4 for Immix Biopharma, Inc. (IMMX) on 10 Dec 2025.

Key facts

This page summarizes Gabriel S. Morris's Form 4 filing for Immix Biopharma, Inc. (IMMX).
4 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 10 Dec 2025, 18:47.

Change

Previous filing in this sequence was filed on 17 Sep 2025.
Current net transaction value: +$129,867.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001889967 Primary reporting owner

Morris Gabriel S

Relationship: CFO, Director
Address: C/O IMMIX BIOPHARMA, INC., 11400 WEST OLYMPIC BLVD., SUITE 200, LOS ANGELES
Signature: /s/ Gabriel Morris
Signature date: 10 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IMMX transaction

Common Stock

Exercise of in-the-money or at-the-money derivative security

Transaction value: $124,800
Shares: +156,000
Change %: +58%
Price: $0.8000
Shares after: 426,844
Date: 08 Dec 2025
Ownership: See footnote
Footnotes: F1

IMMX transaction

Common Stock

Purchase

Transaction value: $5,067
Shares: +770
Change %: +0.26%
Price: $6.58^*
Shares after: 291,429
Date: 10 Dec 2025
Ownership: Direct

IMMX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 24,141
Date: 08 Dec 2025
Ownership: See footnote
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IMMX transaction Derivative

Warrants (right to purchase)

Exercise of in-the-money or at-the-money derivative security

Transaction value: $0
Shares: -96,000
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 08 Dec 2025
Ownership: See footnote
Underlying class: Common stock
Underlying amount: 96,000
Exercise price: $0.8000
Footnotes: F1, F3

IMMX transaction Derivative

Warrants (right to purchase)

Exercise of in-the-money or at-the-money derivative security

Transaction value: $0
Shares: -60,000
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 08 Dec 2025
Ownership: See footnote
Underlying class: Common stock
Underlying amount: 60,000
Exercise price: $0.8000
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Gabriel Morris is the Managing Partner and Sole Member of Alwaysraise LLC ("Alwaysraise") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by Alwaysraise, except to the extent of his pecuniary interest therein.

Footnote F2

Gabriel Morris is the Managing Partner of Alwaysraise Ventures I Investments, LLC ("Alwaysraise Ventures"), the general partner of Alwaysraise Ventures I, LP. ("AVILP") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by AVILP, except to the extent of his pecuniary interest therein.

Footnote F3

The warrants were held by Alwaysraise LLC.